Latest News on MASS

Financial News Based On Company


Advertisement
Advertisement

908 Devices Director Christopher D. Brown Exercises 54,318 Stock Options at $1.75 Each

https://kalkinemedia.com/us/news/announcements/908-devices-director-christopher-d-brown-exercises-54318-stock-options-at-175-each
908 Devices Inc. Director Christopher D. Brown exercised 54,318 stock options at $1.75 per share on November 17, 2026, as disclosed in a Form 4 filing with the SEC on November 18, 2026. This transaction increased his direct beneficial ownership to 829,877 Common Stock shares. The options were fully vested and set to expire on June 22, 2027.

908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates

https://sg.finance.yahoo.com/news/908-devices-inc-mass-reports-121002143.html
908 Devices Inc. (MASS) reported a narrower-than-expected Q3 loss of $0.11 per share, beating the Zacks Consensus Estimate of a $0.16 loss. The company also surpassed revenue estimates, posting $18.95 million against an expectation of $18.56 million. Shares of 908 Devices have significantly outperformed the S&P 500 year-to-date, rising 119.2% compared to the S&P 500's 10.3% gain.

Form 4 908 Devices Inc: John Kenneweg (SVP, Sales & Product Marketing) For: 15 September

https://ca.investing.com/news/stock-market-news/form-4-908-devices-inc-john-kenneweg-svp-sales--product-marketing-for-15-september-93CH-4951064
This article reports on a Form 4 filing for 908 Devices Inc., specifically concerning John Kenneweg, the Senior Vice President of Sales & Product Marketing, for activity on September 15. The article provides the headline and reaffirms the details of the insider transaction report.

Stifel raises 908 Devices stock price target on strong execution

https://www.investing.com/news/analyst-ratings/stifel-raises-908-devices-stock-price-target-on-strong-execution-93CH-5018728
Stifel has increased its price target for 908 Devices Inc. (NASDAQ:MASS) to $14.00 from $12.00, reiterating a Buy rating due to strong execution, a record third quarter for placements, and high revenue since its IPO. The company demonstrated 13% revenue growth over the past year and maintains a solid gross profit margin, benefiting from a focus on security and detection. Despite a recent premarket stock decline, 908 Devices surpassed Q3 earnings and revenue expectations, and raised its full-year sales guidance, with analysts anticipating modest EBITDA positivity by 2027.

908 Devices Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:MASS) 2026-11-11

https://seekingalpha.com/article/4966531-908-devices-inc-2026-q3-results-earnings-call-presentation
908 Devices Inc. published its Q3 2026 earnings call presentation, reporting an EPS of -$0.06, which beat estimates by $0.05, and revenue of $18.95M, a 35.31% year-over-year increase, beating estimates by $644.00K. The slide deck accompanies the earnings call that took place on November 11, 2026.
Advertisement

908 Devices Inc (MASS) (Q3 2026) Earnings Call Highlights: Record $19 Million Revenue, 35% ...

https://sg.finance.yahoo.com/news/908-devices-inc-mass-q3-010600242.html
908 Devices Inc. (MASS) reported a record $19 million in Q3 2026 revenue, a 35% year-over-year increase, driven by strong FTIR product sales and NEARLab law enforcement revenue. The company shipped over 300 devices, a new record, and raised its full-year 2026 revenue guidance to $68.5 million to $70 million. Despite a narrowing adjusted EBITDA loss, the company still reported a net loss of $4.6 million and consumed $2.4 million in cash during the quarter.

908 Devices (MASS) Q3 2026 Earnings Call Transcript

https://www.theglobeandmail.com/investing/markets/markets-news/Motley%20Fool/8765433/908-devices-mass-q3-2026-earnings-call-transcript/
908 Devices Inc. reported strong Q3 2026 results with $19 million in revenue, a 35% year-over-year increase, driven by FTIR product strength and NIRLab integration. The company shipped a record 300+ devices, expanding its installed base to approximately 4,400, and raised its full-year 2026 revenue guidance to $68.5 million to $70 million. Management highlighted progress in scaling proven platforms, extending leadership in aerosol detection, and strengthening recurring revenue through connected services like NIRLab, while also making strides towards reducing adjusted EBITDA losses.

What 908 Devices (MASS) Said on Its Q3 Earnings Call

https://www.tradingview.com/news/marketbeat:5388b1481094b:0-what-908-devices-mass-said-on-its-q3-earnings-call/
908 Devices (MASS) reported record third-quarter revenue of $19 million, a 35% increase year-over-year, and raised its 2026 revenue forecast to $68.5 million to $70 million due to growing international demand for its detection devices. The company is progressing toward adjusted EBITDA break-even while investing in growth and anticipates initial shipments of its next-generation MX908 device by year-end. International customers significantly contributed to revenue, accounting for 40% of the quarter's total.

908 Devices Q3 2026 Earnings Call Transcript

https://www.benzinga.com/news/26/11/63089991/908-devices-q3-2026-earnings-call-transcript
908 Devices reported a strong Q3 2026 with revenue up 35% year-over-year to $19 million, shipping a record 300+ devices and expanding its installed base to approximately 4,400. The company raised its full-year revenue guidance to $68.5-$70 million and is making progress towards reducing its adjusted EBITDA loss. Key growth drivers for 2027 include Near Lab, the next-generation MX908, and potential AVCAD program orders.

908 Devices Inc. (MASS) Tops Q3 EPS by 5c ; Offers Guidance

https://www.streetinsider.com/Earnings/908+Devices+Inc.+%28MASS%29+Tops+Q3+EPS+by+5c+%3B+Offers+Guidance/27318429.html
908 Devices Inc. (NASDAQ: MASS) announced its third-quarter earnings, reporting an EPS of ($0.11), surpassing analyst estimates by $0.05, and revenue of $19 million, exceeding the consensus of $18.57 million. The company also provided its FY2026 revenue guidance, projecting $68.5-70 million against a consensus of $69.12 million.
Advertisement

Form 8K 908 Devices Inc For: 10 November By Investing.com

https://in.investing.com/news/stock-market-news/form-8k-908-devices-inc-for-10-november-93CH-5693443
This article announces that 908 Devices Inc. filed a Form 8K on November 10. The filing, dated November 10, 2026, was published by Investing.com, referencing Reuters for content. The article includes the stock symbol MASS (-0.51%) in relation to the company.

Under a trading plan, 908 Devices (MASS) director Brown sells 30,000 shares averaging $10.95 each.

https://www.stocktitan.net/sec-filings/MASS/form-4-908-devices-inc-insider-trading-activity-fb178fe7f012.html
908 Devices Inc. director Christopher D. Brown sold 30,000 common shares on November 4, 2026, at a weighted average price of $10.95 per share. This transaction was executed under a Rule 10b5-1 trading plan, which was adopted on November 24, 2025. Following the sale, Mr. Brown directly holds 775,559 shares of the company.

A live webcast will be available for 908 Devices’ Stifel conference chat on Nov. 11.

https://www.stocktitan.net/news/MASS/908-devices-to-participate-in-the-stifel-2026-healthcare-tqzael60hb5x.html
908 Devices (Nasdaq: MASS) announced that its management will participate in a fireside chat at the Stifel 2026 Healthcare Conference on November 11, 2026, at 4:00 p.m. ET. A live webcast and an archived replay of the event will be accessible via the "Investors" section of the company's website. The company specializes in purpose-built handheld chemical analysis tools for vital health, safety, and defense applications.

908 Devices Inc. (MASS) Seasonal returns chart

https://au.finance.yahoo.com/quote/MASS/seasonality/
The article provides a seasonal returns chart for 908 Devices Inc. (MASS), showing average monthly price returns from 2020 to 2026. As of the latest data, MASS is trading at 10.56 USD, up 3.43% for the day. The chart aims to help investors understand historical seasonality patterns for the stock.

908 Devices Inc. (MASS) Seasonal returns chart

https://uk.finance.yahoo.com/quote/MASS/seasonality/
This Yahoo Finance article displays the seasonal returns chart for 908 Devices Inc. (MASS). It shows the average monthly price return for the company's stock between 2020 and 2026. As of the article's timestamp, MASS was trading at $10.56, up 3.43%.
Advertisement

908 Devices Inc. (MASS) Seasonal Returns Chart

https://ca.finance.yahoo.com/quote/MASS/seasonality/
The article provides a seasonal returns chart for 908 Devices Inc. (MASS), displaying average monthly price returns from 2020 to 2026. It includes current stock data, showing a closing price of $11.25 with a significant daily drop, followed by a slight dip in after-hours trading.

BlackRock reports a passive stake in 908 Devices (MASS), with sole voting power over 1.99M shares.

https://www.stocktitan.net/sec-filings/MASS/schedule-13g-a-908-devices-inc-amended-passive-investment-disclosure-d6ba394663ea.html
BlackRock, Inc. has filed an amended ownership report (SCHEDULE 13G/A) for 908 Devices Inc. (MASS), indicating a beneficial ownership of 2,039,439 common shares, representing a 4.9% passive stake as of September 30, 2026. BlackRock reports sole voting power over 1,988,695 shares and sole dispositive power over 2,039,439 shares. This filing excludes holdings from other BlackRock business units and confirms that the shares were acquired in the ordinary course of business without the purpose of influencing company control.

908 Devices to Report Third Quarter 2026 Financial Results on November 10, 2026

https://ca.finance.yahoo.com/news/908-devices-report-third-quarter-110000504.html
908 Devices Inc. (Nasdaq: MASS) announced it will report its third-quarter 2026 financial results before the market opens on Tuesday, November 10, 2026. The company will also host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results. Interested parties can access the live audio webcast and its archive on the "Investors" section of the company's website.

908 Devices Inc. Estimates – NASDAQ:MASS

https://www.tradingview.com/symbols/NASDAQ-MASS/financials-estimates/
This article provides access to financial actuals and analyst estimates for 908 Devices Inc. (NASDAQ: MASS) through TradingView. Users can explore reported financial data and compare actual results with average, high, and low estimates across various financial statements. The platform allows visualization of trends over time for income statements, balance sheets, and cash flow.

Form 144 908 DEVICES INC. For: 11 October By Investing.com

https://za.investing.com/news/stock-market-news/form-144-908-devices-inc-for-11-october-93CH-4498659
This article announces the filing of Form 144 for 908 DEVICES INC. on October 11, 2026. The content is a brief notification from Investing.com, providing basic details about the filing without further elaboration. It primarily serves as an alert for interested parties regarding this specific financial document.
Advertisement

Form 144 908 DEVICES INC. For: 11 October By Investing.com

https://ca.investing.com/news/stock-market-news/form-144-908-devices-inc-for-11-october-93CH-4874778
This article announces the filing of Form 144 for 908 DEVICES INC. on October 11th. It is a brief, news-style piece indicating a regulatory filing by the company. The article contains minimal content beyond the title and a stock market reference.

Form 4 908 Devices Inc For: 10 October By Investing.com

https://in.investing.com/news/stock-market-news/form-4-908-devices-inc-for-10-october-93CH-5626844
This article from Investing.com is a brief announcement regarding a Form 4 filing for 908 Devices Inc., pertaining to the date of October 10. It does not provide any further details about the content of the Form 4. The main content of the page consists of general market data, news headlines, and promotional material from Investing.com.

Form 4 908 Devices Inc For: 10 October By Investing.com

https://uk.investing.com/news/stock-market-news/form-4-908-devices-inc-for-10-october-93CH-4903878
This article reports on a Form 4 filing for 908 Devices Inc. for October 10th. It notes that the stock symbol MASS was up 4.33% and was published by Investing.com. The content primarily consists of navigation links, ads, and market data rather than detailed information about the Form 4.

Form 4 908 Devices Inc For: 10 October By Investing.com

https://ca.investing.com/news/stock-market-news/form-4-908-devices-inc-for-10-october-93CH-4874400
This article reports on a Form 4 filing for 908 Devices Inc. on October 10. Form 4 filings typically disclose changes in ownership of company stock by insiders. The article does not provide specific details about the contents of the Form 4.

A director sold 30,000 shares at an average $11.89 each at 908 Devices (MASS).

https://www.stocktitan.net/sec-filings/MASS/form-4-908-devices-inc-insider-trading-activity-f8fa1451739a.html
908 Devices Inc. director Christopher D. Brown sold 30,000 common shares at a weighted average price of $11.89 each on October 7, 2026. This sale was conducted under a Rule 10b5-1 trading plan and followed the exercise of options to acquire 60,000 common shares at $1.75 per share on the same day. Following these transactions, Brown beneficially owns 805,559 common shares and 54,318 stock options.
Advertisement

CFO Griffith Joseph H. IV Sells 5,000 Shares of 908 Devices Inc (MASS)

https://www.gurufocus.com/news/9116390/cfo-griffith-joseph-h-iv-sells-5000-shares-of-908-devices-inc-mass
CFO Griffith Joseph H. IV sold 5,000 shares of 908 Devices Inc (MASS) on October 6, 2026, continuing a trend of insider selling. The company's shares are trading at $13.03, significantly above its GF Value of $7.17, indicating it is "Significantly Overvalued." While insiders are selling, GuruFocus data shows that some institutional investors (gurus) have been adding to their positions, presenting a mixed signal for potential investors.

Under a trading plan, 908 Devices (MASS) CFO Griffith sold 5,000 shares at $13.03 each.

https://www.stocktitan.net/sec-filings/MASS/form-4-908-devices-inc-insider-trading-activity-fb4065965ee6.html
908 Devices Inc. CFO Joseph H. Griffith IV sold 5,000 shares of common stock at $13.03 per share on October 6, 2026, under a pre-arranged Rule 10b5-1 trading plan. Following this transaction, Griffith directly holds 116,497 shares in the company. The sale amounted to $65,150 and was executed as part of a plan adopted on May 26, 2026.

An officer proposes selling 5,000 shares of 908 Devices (NASDAQ: MASS), valued at $64,000.

https://www.stocktitan.net/sec-filings/MASS/144-908-devices-inc-sec-filing-81927ea8b639.html
Joseph Griffith, an officer at 908 Devices Inc. (NASDAQ: MASS), has proposed selling 5,000 common shares with an approximate market value of $64,000, with an approximate sale date of October 6, 2026. These shares were acquired as restricted stock units on February 1, 2025. The filing also disclosed a past sale of 11,459 common shares on August 25, 2026, for $125,434.95 under a 10b5-1 sales plan.

Biotech Stocks At 52-Week Highs - KOD, MASS, OBIO, CDNA, PMVP

https://www.rttnews.com/amp/3696059/biotech-stocks-at-52-week-highs-kod-mass-obio-cdna-pmvp.aspx
Several biotech stocks, including Kodiak Sciences (KOD), 908 Devices (MASS), Orchestra BioMed (OBIO), CareDx (CDNA), and PMV Pharmaceuticals (PMVP), reached 52-week highs on October 1, 2026. These gains were primarily driven by positive clinical trial results, strong financial performance, and breakthrough device designations from the FDA for their respective therapies and technologies. The companies operate in diverse areas such as retinal diseases, chemical analysis, vascular conditions, transplant diagnostics, and oncology.

A 10% owner sells 18,000 shares of 908 Devices (MASS) at an average $11.5179 each.

https://www.stocktitan.net/sec-filings/MASS/form-4-908-devices-inc-insider-trading-activity-0fc0ee66d460.html
AWM Investment Company, a 10% owner of 908 Devices Inc. (MASS), sold 18,000 common shares indirectly at a weighted average price of $11.5179 per share on September 29, 2026. Following this transaction, AWM's reported indirect position in the company is 4,736,773 shares. The sale, detailed in a Form 4 filing, indicates a negative sentiment and moderate impact, with AWM disclaiming beneficial ownership except for its pecuniary interest.
Advertisement

Form 4 908 Devices Inc For: 26 September By Investing.com

https://ng.investing.com/news/stock-market-news/form-4-908-devices-inc-for-26-september-93CH-2710544
This article announces the filing of Form 4 by 908 Devices Inc. for transactions that occurred on September 26. It is a brief news item published by Investing.com, providing basic information about the regulatory filing. The content itself is very short and simply states the fact of the filing.

Awm investment sells $283k in 908 Devices stock By Investing.com

https://in.investing.com/news/stock-market-news/awm-investment-sells-283k-in-908-devices-stock-93CH-5607462
AWM Investment Company, a significant shareholder and director of 908 Devices Inc., recently sold common stock valued at $283,875. These transactions involved 25,000 shares sold over two days in late September 2026, at prices ranging from $11.25 to $11.3594 per share. The sales occurred while the stock was near its 52-week high, with InvestingPro data suggesting it is overvalued despite a 117% year-to-date return.

Form 4 908 Devices Inc For: 26 September By Investing.com

https://ca.investing.com/news/stock-market-news/form-4-908-devices-inc-for-26-september-93CH-4854406
This article reports on the filing of Form 4 for 908 Devices Inc. on September 26, 2026. The Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a material change in the holdings of company insiders. The brief news piece indicates that this filing is now available for public review.

Awm investment sells $283k in 908 Devices stock By Investing.com

https://www.investing.com/news/insider-trading-news/awm-investment-sells-283k-in-908-devices-stock-93CH-4918442
AWM Investment Company, Inc., a significant owner of 908 Devices Inc. (NASDAQ:MASS), sold 25,000 shares of common stock for a total of $283,875 in late September 2026. These transactions occurred as the stock was trading near its 52-week high, with InvestingPro indicating it might be overvalued despite a 117% year-to-date return. Following the sale, AWM Investment Company still beneficially owns over 4.7 million shares of 908 Devices.

A 10% owner sold 1,000 and 24,000 shares of 908 Devices (MASS) on consecutive days.

https://www.stocktitan.net/sec-filings/MASS/form-4-908-devices-inc-insider-trading-activity-3dd8f848fe2f.html
AWM Investment Company, Inc., a 10% owner of 908 Devices Inc. (MASS), reported two indirect sales of common stock. On September 23, 2026, 1,000 shares were sold at $11.25 each, and on September 24, 2026, 24,000 shares were sold at $11.3594 each, totaling 25,000 shares sold for approximately $284K. Following these transactions, AWM Investment Company's reported holdings were 4,754,773 shares.
Advertisement

Roth MKM Maintains 908 Devices(MASS.US) With Buy Rating, Raises Target Price to $14

https://www.moomoo.com/news/post/1000049408/roth-mkm-maintains-908-devices-massus-with-buy-rating-raises
Roth MKM has reiterated its Buy rating on 908 Devices (MASS.US) and increased its price target to $14. This positive revision from the analyst firm indicates continued confidence in the company's performance and future prospects. Investors may view this as a favorable outlook for 908 Devices' stock.

908 Devices Inc Lobbyists, 2025

https://www.opensecrets.org/federal-lobbying/clients/908-devices-inc/lobbyists?client_id=137613&cycle=2025
This OpenSecrets page details the lobbying activities for 908 Devices Inc. in 2025. The company spent $95,000 on federal lobbying, exclusively direct spending. Two lobbyists were named, both with prior federal government experience, and they were employed by Brendan Neal Strategies and National Group LLP.

Canaccord initiates 908 Devices stock coverage with buy rating By Investing.com

https://ng.investing.com/news/stock-market-news/canaccord-initiates-908-devices-stock-coverage-with-buy-rating-93CH-2691279
Canaccord has initiated coverage on 908 Devices Inc. (NASDAQ:MASS) with a buy rating and a price target of $13.50. The company, which specializes in handheld chemical analysis equipment for defense and public safety, has seen its stock surge by 84.57% year-to-date, though InvestingPro suggests it may be overvalued. This follows recent positive revenue growth and a price target increase from Stifel, despite a wider-than-expected loss per share in the last quarter.

908 Devices Insider Christopher D. Brown Sells 30,000 Shares at $10.58 on September 2, 2026 (NASDAQ: MASS)

https://kalkinemedia.com/us/news/announcements/908-devices-insider-christopher-d-brown-sells-30000-shares-at-1058-on-september-2-2026-nasdaq-mass
908 Devices Inc. insider Christopher D. Brown sold 30,000 shares of the company's stock at $10.58 per share on September 2, 2026. Following this transaction, Brown's remaining ownership in 908 Devices (NASDAQ: MASS) stands at 775,559 shares. This sale provides insight into the insider trading activity and Brown's current stake in the company.

908 Devices: director Brown sells $317,400 of common stock By Investing.com

https://za.investing.com/news/stock-market-news/908-devices-director-brown-sells-317400-of-common-stock-93CH-4455061
Christopher D. Brown, a Director at 908 Devices Inc. (NASDAQ:MASS), recently sold 30,000 shares of common stock for $317,400 under a Rule 10b5-1 trading plan. Following the sale, Mr. Brown still beneficially owns 775,559 shares. This insider sale occurs as the stock has shown significant momentum, despite InvestingPro analysis suggesting it may be overvalued.
Advertisement

Director at 908 Devices (NASDAQ: MASS) sells 30,000 shares under 10b5-1 plan

https://www.stocktitan.net/sec-filings/MASS/form-4-908-devices-inc-insider-trading-activity-a925ba826ae3.html
A director at 908 Devices Inc. (NASDAQ: MASS), Christopher D. Brown, sold 30,000 shares of common stock on September 2, 2026, at a weighted average price of $10.58 per share. This sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted in November 2025. Following the transaction, Brown directly holds 775,559 shares of the company.

908 Devices: director Brown sells $317,400 of common stock

https://www.investing.com/news/insider-trading-news/908-devices-director-brown-sells-317400-of-common-stock-93CH-4890016
Christopher D. Brown, a director at 908 Devices Inc. (NASDAQ:MASS), recently sold 30,000 shares of common stock totaling $317,400, executed under a Rule 10b5-1 trading plan. Despite the insider sale, the stock has shown significant momentum with a 91% year-to-date return, though InvestingPro analysis suggests it may be overvalued. The company recently reported stronger-than-expected Q2 2026 revenue and raised its full-year sales outlook, leading Stifel to increase its price target and maintain a Buy rating.

908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium

https://finance.yahoo.com/technology/articles/908-devices-present-32nd-annual-110000290.html
908 Devices Inc. (Nasdaq: MASS) announced its participation in the 32nd Annual Gabelli Aerospace & Defense Symposium on September 10, 2026, in New York City. Company management is scheduled to present at 3:45 p.m. Eastern Time, with a webcast registration available through Gabelli's website. An archived webcast will be accessible on the company's investor relations website approximately one week after the event.

908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates

https://www.tradingview.com/news/marketbeat:6ed25b1a0094b:0-908-devices-raises-2026-outlook-as-handheld-detection-demand-accelerates/
908 Devices (MASS) has raised its 2026 revenue outlook to $68 million to $70 million, driven by accelerating demand for handheld chemical detection tools in public health, safety, and CBRNE defense applications. The company reported strong Q2 2026 results with 23% year-over-year revenue growth and a diversified customer base, with over 50% of revenue coming from state and local customers. Strategic initiatives include the acquisition of NIRLab, which adds recurring subscription revenue, and the development of a next-generation handheld mass spectrometry platform to capitalize on modernization opportunities and growing market needs for illicit drug detection and chemical safety.

908 Devices (MASS) officer plans $125K stock sale

https://www.stocktitan.net/sec-filings/MASS/144-908-devices-inc-sec-filing-129c92e853a5.html
Joseph Griffith, an officer at 908 Devices Inc. (MASS), has filed a Rule 144 notice to sell 11,459 shares of common stock, valued at approximately $125,132. The shares were acquired through the vesting of restricted stock units between February 2025 and February 2026. This filing also references a previous 10b5-1 sale of 6,940 shares on May 28, 2026.
Advertisement

AWM Investment Company, Inc. Trims 908 Devices Inc (MASS) Stake

https://www.gurufocus.com/news/9050699/awm-investment-company-inc-trims-908-devices-inc-mass-stake-shares-remain-significantly-overvalued-on-gf-value
AWM Investment Company, Inc. has reduced its stake in 908 Devices Inc (MASS) by 50,000 shares, a 1.04% decrease in its position, despite the stock's significant year-to-date appreciation. The firm maintains a substantial holding in 908 Devices, which is considered "Significantly Overvalued" by GuruFocus with weak profitability metrics but strong financial health and momentum. This modest reduction reflects a cautious approach to risk management given the stock's current valuation and recent surge.

AWM trims 50,000-share stake in 908 Devices Inc. (MASS) stock

https://www.stocktitan.net/sec-filings/MASS/form-4-908-devices-inc-insider-trading-activity-1493f2fcfc58.html
AWM Investment Company, Inc., a ten percent owner of 908 Devices Inc. (MASS), indirectly sold 50,000 shares of common stock on August 20-21, 2026, through limited partnerships it advises. The sales occurred at weighted average prices between $10.52 and $10.61 per share. AWM disclaims beneficial ownership except for its pecuniary interest, as detailed in the Form 4 filing.

908 Devices (MASS) Q2 2026 Earnings Call Transcript

https://www.theglobeandmail.com/investing/markets/stocks/MASS/pressreleases/3910892/908-devices-mass-q2-2026-earnings-call-transcript/
908 Devices (MASS) reported strong Q2 2026 results, with total revenue up 23% year-over-year to $16.1 million, driven by increased product volume for VipIR and the addition of NIRLAB revenue. The company significantly improved its Adjusted EBITDA loss by 50% to $1.9 million and raised its full-year 2026 revenue guidance to $68 million to $70 million. Key growth drivers include strong performance in U.S. state and local markets, strategic acquisition of NIRLAB, and increasing demand for its detection technologies, despite delays in the U.S. military's AVCAD program.

908 Devices (MASS) Q2 2026 Earnings Call Transcript

https://www.theglobeandmail.com/investing/markets/markets-news/motley/3910892/908-devices-mass-q2-2026-earnings-call-transcript/
908 Devices (MASS) reported strong Q2 2026 earnings with 23% revenue growth to $16.1 million, driven by increased product volume for VipIR and the acquisition of NIRLAB. The company saw a 50% improvement in adjusted EBITDA loss, reducing it to $1.9 million. Key drivers included robust demand from U.S. state and local agencies, successful integration of NIRLAB, and strategic expansion of its infrared detection devices.

908 Devices CEO Knopp sells $283,677 in common stock

https://www.investing.com/news/insider-trading-news/908-devices-ceo-knopp-sells-283677-in-common-stock-93CH-4864045
Kevin J. Knopp, CEO of 908 Devices Inc. (NASDAQ: MASS), sold 27,622 shares of company stock for a total of approximately $283,677 through a Rule 10b5-1 trading plan. These sales occurred as the stock neared its 52-week high and InvestingPro analysis indicated the stock might be overvalued and in overbought territory. Despite this, the company recently reported better-than-expected Q2 2026 revenue and raised its full-year sales outlook, leading Stifel to increase its price target.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement